Molecular Target Synopsis
Overview
Domains and Structures
Drugs and Clinical Candidates
Druggability
Chemistry
Ligand Efficiency Plot
Pathways
Family Cladogram
Interaction Network
Gene Expression
Gene Copy Number Variation
RNAi
Mutations
Germline Genetics

ACSM2B (Q68CK6) - Overview - Molecular Target Synopsis

Protein


ACSM2B, Acyl-coenzyme A synthetase ACSM2B, mitochondrial
Enzyme Classification 6.2.1.2
UniProt Q68CK6

Also Known as ACS2B_HUMAN, ACSM2B, ACSM2

Has medium-chain fatty acid:CoA ligase activity with broad substrate specificity (in vitro). Acts on acids from C(4) to C(11) and on the corresponding 3-hydroxy- and 2,3- or 3,4-unsaturated acids (in vitro). Monomer.

Isoforms / Transcripts (Protein Coding)


Sub-cellular localization


UniProt: ACSM2B is active in the following subcellular-locations: mitochondrion matrix.
GO terms: ACSM2B is active in the following subcellular-locations: mitochondrial matrix, mitochondrion.



UniProt
GO terms

Gene Copy Number Variation


In COSMIC - Cell Lines Project ACSM2B has gain in 1 cell-lines, loss in 1 cell-lines and no signal in 1003 cell-lines. (see details)

Gene Expression


In NCI60, the highest expressing cell lines are:

In Array Express (RNA-seq of 675 commonly used human cancer cell lines), the highest expressing cell lines are: Hs 746T, NCI-H209, LN-18

In Array Express (RNA-seq of long poly adenylated RNA and long non poly adenylated RNA from ENCODE cell lines), the highest expressing cell lines are: SK-N-SH, NHLF, HSMM

(see details)

3D Structures


At greater than 90% identity similarity to ACSM2B there are:
7 structures (13 chains) solved
6 are solved in complex with at least one small molecule ligand
3 are solved with an approved drug

ACSM2B is solved in complex with the approved drug(s):

AMP/ADENOSINE PHOSPHATE (2VZE_A, 2VZE_B, 2VZE_C, 3EQ6_A, 3EQ6_B),
IBP/DEXIBUPROFEN (2WD9_A, 2WD9_B, 2WD9_C).

(see details)
Molecular Target 3D Synopsis

Screening and Chemistry


ACSM2B has been screened with compounds ( bioactivities). (see details)